Steven Wang

Steven Wang is an experienced professional in venture investments and corporate development, currently serving as Vice President of Venture Investments at Novo Holdings since March 2022. Additionally, Steven holds positions as a Board Observer for OnCusp Therapeutics and Inspirna, Inc. Previously, Steven was Associate Director of Corporate Development at Korro Bio, Inc. and contributed as an Investment Analyst at SV Health Investors. Steven has expertise in strategy, operations, and competitive intelligence within the biopharma and healthcare sectors, supported by a Ph.D. in Molecular Biology and Genetics from The Johns Hopkins University School of Medicine and a B.A. in Biochemistry and Biology from the University of Pennsylvania.